期刊文献+

马A3Z3V1抑制马传染性贫血病毒早晚期反转录的鉴定

Inhibition of equine infectious anemia virus early and late reverse transcripts by A3Z3V1
下载PDF
导出
摘要 马A3Z3V1是宿主细胞内的一种APOBEC3免疫因子,它可以有效抑制马传染性贫血病毒(EIAV)在马宿主细胞内的复制。为鉴定马A3Z3V1分子对EIAV早晚期反转录的抑制作用,本实验根据EIAV的R/U5和gag基因序列分别设计了检测EIAV早晚期反转录产物的引物并建立了SYBR GreenⅠ荧光定量PCR方法,利用该方法评价免疫因子A3Z3V1对EIAV逆转录过程的影响。结果显示,在早期反转录过程中,A3Z3V1可以使EIAV的反转录产物最高减少7倍;在晚期反转录过程中,A3Z3V1可以使EIAV的反转录产物最高减少3倍。本实验结果将有助于进一步研究APOBEC3分子的抗病毒作用机制。 The equine A3Z3V1 is a kind of APOBEC3 immune factors in host cells, it is capable of efficiently inhibiting the replication of equine infectious anemia virus (EIAV) in host cells. To identify the inhibition of EIAV early and late reverse transcription, the SYBR Green1 real time PCR was established based on the primers targeting repeat-5’UTR sequence for early and the gag gene for late reverse transcription detection of provirus DNA of EIAV. In addition, the inhibition of A3Z3V1 was assayed in the procedure of EIAV early and late reverse transcription in fetal dermal donkey cells which was infected with the EIAV harvested from HEK293T cells co-transfected with EIAV infectious clone of pLG-UK3 and pcDNA-A3Z3V1. The results indicated that A3Z3V1 was able to decrease 7-fold reverse transcripts in the course of early reverse transcription, and 3-fold in the course of late reverse transcription. These results might facilitate future study on the antiviral mechanism of APOBEC3 in equine.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2013年第9期695-697,共3页 Chinese Journal of Preventive Veterinary Medicine
基金 国家自然科学基金(31072113 31222054) 兽医生物技术国家重点实验室自主课题(SKLVBP2012 SKLVBP201304) 中央级公益性基本科研业务费预算增量项目(2012ZL080)
关键词 马A3Z3V1 马传染性贫血病毒 相对荧光定量PCR 早晚期反转录 A3Z3V1 equine infectious anemia virus relative real-time PCR early and late reverse transcription
  • 相关文献

参考文献2

二级参考文献42

  • 1白如珺,刘新泳.HIV-1转录反式激活及其抑制剂[J].药学学报,2006,41(4):289-295. 被引量:6
  • 2Liang H, He X, Shen T, et al, Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV [J]. Arch Virol, 2006, 151(7): 1387-1403.
  • 3Shen T, Liang H, Tong X, et al. Amino acid mutations of an infectious clone of Chinese EIAV attenuated vaccine resulted in reversion of virulence [J]. Vaacine, 2006, 24(6): 738-749.
  • 4Zhang X, Wang Y, Liang H, et al. Correlation between the induction of Thl cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression [J]. J Gen Virol, 2007, 88(3): 998-1004.
  • 5陈新江,张耀洲,张晓燕.马传染性贫血病毒表面蛋白基因的克隆与表达[A].华东六省一市生物化学与分子生物学学会2006年学术交流会论文集[C].中国杭州,2006.
  • 6Craigo J K, Durkin S, Sturgeon T J, et al. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines [J]. Vaccine, 2007, 25(5): 834-845.
  • 7Li F, Craigo J K, Howe L, et al. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses [J]. J Virol, 2003, 77(13): 7244-7253.
  • 8Shen R X, Xu Z D, He X S, et al. Study on immunological methods of equine infectious anemia [J]. China Agric Sci, 1979, 111-115.
  • 9Tschetter J R, Byrne K M, Perryman L E, et al. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies [J]. Virology, 1997, 230(2): 275-280.
  • 10Mulky A, Kappes JC. Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells [ J]. Antimicrob Agents Chemother, 2005,49:3762 - 3769.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部